DMTRF Projected Dividend Yield
3-D Matrix, Ltd ( OTCBB : DMTRF )3-D Matrix is engaged in the development businesses consisting of research reagents, medical devices, and licensing based on various rights associated with self-assembling peptide technologies. Co. develops feasible technologies in the fields of regenerative medicine, surgical treatment, cell therapy, and drug discovery. Co.'s core technology, self-assembling peptide "PuraMatrix™" consists of an amphipathic peptide that forms nanofibers from the change in pH or the response to inorganic salts contained in solutions. Co.'s principal products include "PuraMatrix™," "High Concentration PuraMatrix™," "Modified Peptide" and "GMP Grade PuraMatrix™." 21 YEAR PERFORMANCE RESULTS |
DMTRF Dividend History Detail DMTRF Dividend News DMTRF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |